Lymph node removal range for advanced stomach cancer
Part of Cancer, Digestive system clinical trials.
This study is looking at how far surgeons should remove lymph nodes during surgery for advanced stomach cancer. It may help doctors decide the best way to remove cancer while reducing side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have stomach cancer that has been confirmed by a biopsy.
- You are scheduled for a type of stomach surgery called laparoscopic distal subtotal gastrectomy, and the surgeon plans to remove nearby lymph nodes.
- Your cancer is at a stage where it has grown into the stomach wall (T2 to T4a) but has not spread to distant organs.
- You have not had chemotherapy or radiation therapy before.
- You are in generally good health, with no major uncontrolled heart, liver, kidney, or lung problems, and you can care for most of your daily needs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a minimally invasive camera-guided surgical procedure (laparoscopy) can better detect hidden cancer spread in patients with advanced stomach cancer. The goal is to help doctors plan the best treatment and improve outcomes.
This study tests whether a new set of surgical tools can help remove the entire stomach using small incisions (laparoscopy). It is for people with stomach cancer that hasn't spread widely and who are healthy enough for surgery.
This trial compares two ways of removing lymph nodes during surgery: keyhole (laparoscopic) versus open surgery. It is for people with esophagus-stomach junction adenocarcinoma, aiming to see which approach works better and is safer.
This trial looks at how many lymph nodes should be removed during surgery for advanced right-sided colon cancer. It may help determine the best treatment approach for patients who haven't had other cancer treatments yet.
This trial studies whether removing all of the fatty lining (omentum) or only part of it during surgery leads to better outcomes in people with advanced stomach cancer. It also checks that participants can safely have the same stomach-cancer chemotherapy plan after surgery.
This trial studies the importance of checking lymph nodes in the fatty tissue around the stomach during stomach cancer surgery. It helps doctors understand if examining these specific areas can improve treatment decisions.
Hear when a new Gastric Cancer (GC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.